GuiZhou SanLi Pharmaceutical Co.,LTD. provided earnings guidance for the first Half of 2020. The Company predicts the net profit belonging to shareholders of the listed company in the 1st half of 2020 will be between RMB 42 million and RMB 47 million. During the report period, the net profit belonging to shareholders of the listed company after excluding extraordinary profit and loss will be between RMB 44 million and RMB 49 million.